首页> 外文会议>International Workshop on Cardiac Arrhythmias >Dual-chamber ICDs: How Effective and Safe Are They in the Treatment of Atrial Tachyarrhythmias?
【24h】

Dual-chamber ICDs: How Effective and Safe Are They in the Treatment of Atrial Tachyarrhythmias?

机译:双室ICDS:它们在治疗心房Tachyarrhalythmias时如何有效和安全?

获取原文

摘要

The rapid development of internal cardioverter defibrillator (ICD) technology in the late 1990s resulted in the construction of sophisticated dual-chamber devices. Initially, the rationale behind their introduction was the possibility of sequential pacing for bradyarrhythmia whenever required, thus avoiding the need for parallel pacemaker implantation. At the same time, the use of an atrial lead was viewed as an opportunity to improve discrimination between supraventricular and ventricular arrhythmias. The experience obtained with atrial defibrillators and in studies on pacing prevention of atrial fibrillation was subsequently also exploited in novel ICD devices. Now, as they have such a powerful tool available, some clinicians suggest the use of dual-chamber devices in all ICD candidates who are in sinus rhythm [1]. Indeed, most ICDs currently implanted in the USA are dual-chamber devices [2]. On the other hand, there is mounting evidence that such an approach is not devoid of risk. Therefore, the purpose of this review is to discuss the pros and cons of dual-chamber ICDs.
机译:内部Cardioverter除颤器(ICD)技术在20世纪90年代后期的快速发展导致建造复杂的双室设备。最初,其引入背后的理由是在需要时对Bradyarrhythmia连续起搏的可能性,从而避免了对平行起搏器植入的需求。同时,使用心房引线被视为改善髁上和心律失常之间歧视的机会。随后在新型ICD装置中,随后利用了心房除颤器和高静纤维化预防的研究的经验。现在,由于它们具有如此强大的工具,一些临床医生建议使用在鼻窦节奏中的所有ICD候选人中的双室设备[1]。实际上,目前植入美国的大多数ICD是双室设备[2]。另一方面,有证据表明这种方法不缺乏风险。因此,本综述的目的是讨论双室ICD的利弊。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号